Professional Documents
Culture Documents
1
Dyspepsia – Definition Dyspepsia – Important problem Dyspepsia – Causes
Any symptom of Upper GI Tract ≥4w Common
including: 40% adults suffer; 5% consult; 1% referred annually
Upper abdominal pain/discomfort
Heartburn/acid reflux
Significant impact on QoL
Nausea/vomiting
Findings at Endoscopy: England 1994 (Source: Hospital Episode Statistics) Findings at Endoscopy: England 1994 (Source: Hospital Episode Statistics) Findings at Endoscopy: England 1994 (Source: Hospital Episode Statistics)
2
Dyspepsia – Causes Common elements of care 1 Common elements of care 2
Gastric cancer Oesophageal cancer Medication review Lifestyle advice
Peptic ulcer
2% 1%
Misc
Look for possible causes Simple advice:
3% 5% NSAIDs CCB Eat healthily, Lose weight, Stop smoking
Duodenal ulcer Corticosteroids Nitrates Avoid known precipitants (if associated with symptoms):
5%
Bisphosphonates Theophyllines Smoking, Alcohol, Coffee, Chocolate, Fatty foods
Raising head of bed, Main meal well before bed may
Gastric ulcer
5%
If referral required, suspend NSAID help
Recurrent or Long-
Long-term dyspepsia
Test & treat for H pylori Regular review (minimum annually)
Encourage and empower pts to reduce use of
or prescribed medication stepwise:
Lowest effective dose
Empirical PPI Full dose, 1m On-
On-demand use
Return to self-
self-treatment with antacid/alginate
Consider managing previously investigated patients
without new alarm signs according to previous
endoscopic findings
3
H pylori – Non-
Non-invasive tests H pylori – Eradication therapy Case 2 Complicated dyspepsia
British National Formulary - Section 1.3 Brian Smith ♂44
Test Sensitivity Specificity PPV1 Unit cost
3m Progressive epigastric pain,
Wt↓
Wt↓ 10kg, Occasional vomiting
Lab Serology 92% 83% 64.3% £9.61
First line
PMH: Nil of note Alarm signs
13C-Urea Breath Test 2 94.7% 95.7% 87.9% £18.80 PAC500 / PMC250 1w
DH: Nil
85% effective
mAb Stool Ag test2 97.6% 95.9% 88.7% £11.43 Exam: ?Epigastric
?Epigastric mass
pAb Stool Ag test2 92.4% 91.9% 79.1% £11.43
1
Second line
assuming prevalence 25%
2
2 week washout period following PPI necessary before test PPI + TriK dicitratobismuthate + Tet + Met 2w
4
Uninvestigated
Medication
review
No response
or relapse Gastro-
Gastro-oesophageal reflux
disease (GORD)
Response
Full-
Full-dose PPI 1-1-2m
Test and
Treat
treat
No response Inadequate response:
or relapse Double-
Double-dose PPI or
Relapse Full dose Response
H2RA/Prokinetic 1m
PPI 1m Recurrent sx:
sx: Lowest
No response effective dose PPI
Surgery not routine
Low-dose H2RA or
treatment
Response
Prokinetic Oesophageal stricture
as required 1m dilatation: Long-
Long-term full-
full-
No response dose PPI
Review Self-care